1361. Pharmacokinetics and Safety of Ridinilazole (RDZ), a Potential New Therapy for Clostridium difficile Infection (CDI): From Animal Models to Patients
1361. 利地尼唑 (RDZ) 的药代动力学和安全性：一种治疗艰难梭菌感染 (CDI) 的潜在新疗法：从动物模型到患者
期刊:International Journal of Hepatology
影响因子:1.4
doi:10.1155/2020/9185361
Danish, Lubna; Siddiq, Riffat; Jahan, Sarwat; Taneez, Mehwish; Khan, Manzoor; Sandhu, Marva; Natividad Bisquera, Nichole Andrea; Mirasol, Roberto Cachola; Pruskowski, Kaitlin A; Britton, Garrett W; Mitchell, Thomas A; Cancio, Leopoldo C; Cari, Evelyn Villacorta; Leedy, Nicole; Ribes, Julie A; Soria, Jaime; Myint, Thein; Alaoui, A; Oumedjbeur, K; Djinbachian, R; Marchand, E; Marques, P; Hammar, C; Pohl, H; Bouin, M; Deslandres, E; Bouchard, S; von Renteln, D; Duperchy, Esther; Chowdhury, Sumita; Vickers, Richard; Robinson, Neil
